4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-049653
Director sold 5,000 shares at an average $180.42 ($902,102)
From the SEC's structured data for this filing
Trades in this filing
STUELPNAGEL JOHN R · Director
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-02 | Sale : show line 1 in the form | −1,100 | $178.48 | $196,323 | 390,516 | D |
| 2021-08-02 | Sale : show line 2 in the form | −1,140 | $179.53 | $204,669 | 389,376 | D |
| 2021-08-02 | Sale : show line 3 in the form | −960 | $180.33 | $173,115 | 388,416 | D |
| 2021-08-02 | Sale : show line 4 in the form | −1,100 | $181.47 | $199,620 | 387,316 | D |
| 2021-08-02 | Sale : show line 5 in the form | −400 | $182.74 | $73,096 | 386,916 | D |
| 2021-08-02 | Sale : show line 6 in the form | −200 | $183.90 | $36,780 | 386,716 | D |
| 2021-08-02 | Sale : show line 7 in the form | −100 | $184.99 | $18,499 | 386,616 | D |
| Open-market sales · 5,000 sh · avg $180.42 · $902,102 | ||||||
Loading xslF345X03/doc4.xml…